Poietis

Poietis is a biotechnology company ­specialized in the development and manufacturing of ­human tissues by 4D bioprinting. The bioprinting technology of Poietis, whose ­company is licensed exclusively and worldwide, is the result of an innovative research ­conducted for ten years by Inserm and the University of ­Bordeaux. Before joining Poietis, Bertrand worked 10 years at Mauna Kea Technologies (listed company based in Paris) as R&D Manager to develop the most miniaturized microscope in the world dedicated to medical imaging in vivo. Poietis mission is to provide solutions leveraging a proprietary, innovative Next-Generation Bioprinting platform and bring Tissue Engineering therapies to patients. Poietis is a spin-off from INSERM and University of Bordeaux where Laser-Assisted Bioprinting Technology was initially developed. Poietis brings to the market two bioprinters based on Next-Generation Bioprinting platform. On the basis of its expertise in bioprinting ­technologies and in particular high resolution ­laser bioprinting, Poietis has also developed the ­multimodal bioprinting platform NGB (« Next ­Generation Bioprinting »). Besides the NGB-R ­commercial ­bioprinter ­dedicated to R&D, the compagny is developing the NGB-C ­system for clinical applications.